← 產業報告目錄
Wearable Injectors Market Size, Share & Trends Analysis Report By Type of Device (Patch Pump / Injectors, Infusion Pump / Injectors), By Usability (Disposable, Reusable), By Therapeutic Area, By Region, And by Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-07頁數 179報告編號 INSIGHTACE-5b15848a77
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
Valued at USD 4.16 Bn as of 2023, the global Wearable Injectors Market is anticipated to climb to USD 7.87 Bn by 2031, reflecting a compound annual growth rate of 8.44% over the 2024–2031 period.
The Wearable Injectors sector involves small drug delivery systems intended to continuously administer medications for extended periods. This domain has witnessed marked transformation owing to technological breakthroughs and shifting healthcare dynamics.
Market momentum is fueled by expanding interest in advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, fueled by rapid industrialization and expanding end-user bases.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Wearable Injectors Market Snapshot
Chapter 4. Global Wearable Injectors Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Type of Device Estimates & Trend Analysis
5.1. By Type of Device, & Market Share, 2023 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Type of Device:
5.2.1. Patch Pump / Injectors
5.2.2. Infusion Pump / Injectors
Chapter 6. Market Segmentation 2: By Usability Estimates & Trend Analysis
6.1. By Usability & Market Share, 2023 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Usability:
6.2.1. Disposable
6.2.2. Reusable
Chapter 7. Market Segmentation 3: By Therapeutic Area Estimates & Trend Analysis
7.1. By Therapeutic Area & Market Share, 2023 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Therapeutic Area:
7.2.1. Autoimmune Disorders
7.2.2. Cardiovascular Disorders
7.2.3. Metabolic Disorders
7.2.4. Neurological Disorders
7.2.5. Oncological Disorders
7.2.6. Other Disorders
Chapter 8. Wearable Injectors Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Wearable Injectors Market revenue (US$ Million) estimates and forecasts By Type of Device, 2019-2031
8.1.2. North America Wearable Injectors Market revenue (US$ Million) estimates and forecasts By Usability, 2019-2031
8.1.3. North America Wearable Injectors Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2019-2031
8.1.4. North America Wearable Injectors Market revenue (US$ Million) estimates and forecasts by country, 2019-2031
8.2. Europe
8.2.1. Europe Wearable Injectors Market revenue (US$ Million) By Type of Device, 2019-2031
8.2.2. Europe Wearable Injectors Market revenue (US$ Million) By Usability, 2019-2031
8.2.3. Europe Wearable Injectors Market revenue (US$ Million) By Therapeutic Area, 2019-2031
8.2.4. Europe Wearable Injectors Market revenue (US$ Million) by country, 2019-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Wearable Injectors Market revenue (US$ Million) By Type of Device, 2019-2031
8.3.2. Asia Pacific Wearable Injectors Market revenue (US$ Million) By Usability, 2019-2031
8.3.3. Asia Pacific Wearable Injectors Market revenue (US$ Million) By Therapeutic Area, 2019-2031
8.3.4. Asia Pacific Wearable Injectors Market revenue (US$ Million) by country, 2019-2031
8.4. Latin America
8.4.1. Latin America Wearable Injectors Market revenue (US$ Million) By Type of Device, (US$ Million) 2019-2031
8.4.2. Latin America Wearable Injectors Market revenue (US$ Million) By Usability, (US$ Million) 2019-2031
8.4.3. Latin America Wearable Injectors Market revenue (US$ Million) By Therapeutic Area, (US$ Million) 2019-2031
8.4.4. Latin America Wearable Injectors Market revenue (US$ Million) by country, 2019-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Wearable Injectors Market revenue (US$ Million) By Type of Device, (US$ Million) 2019-2031
8.5.2. Middle East & Africa Wearable Injectors Market revenue (US$ Million) By Usability, (US$ Million) 2019-2031
8.5.3. Middle East & Africa Wearable Injectors Market revenue (US$ Million) By Therapeutic Area, (US$ Million) 2019-2031
8.5.4. Middle East & Africa Wearable Injectors Market revenue (US$ Million) by country, 2019-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. CCBio
9.2.2. CeQur
9.2.3. Debiotech
9.2.4. E3D Elcam Drug Delivery Devices
9.2.5. Eli Lilly
9.2.6. Enable Injections
9.2.7. Gerresheimer
9.2.8. Insulet
9.2.9. Medtronic
9.2.10. Medtrum Technologies
9.2.11. Pharmasense
9.2.12. Roche
9.2.13. Sonceboz
9.2.14. Weibel CDS
9.2.15. West Pharmaceuticals
9.2.16. SOOIL Development
9.2.17. Becton, Dickinson and Company
9.2.18. Johnson & Johnson Services, Inc.
9.2.19. Elcam Drug Delivery Devices (Israel)
9.2.20. Recipharm AB. (U.K)
9.2.21. Stevanato Group (Italy)
9.2.22. Sorrel Medical (Israel)
9.2.23. Others
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們